51 filings
Page 2 of 3
8-K
92noc8
28 Mar 23
SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results
4:24pm
8-K
zq327nqfojpgl8
23 Mar 23
Departure of Directors or Certain Officers
4:34pm
8-K
6y266do4op rql0c6o3
9 Mar 23
In the Court of Chancery of the State of Delaware
4:37pm
8-K
0p4kzqrqgm5x9e5g6d6
17 Feb 23
In the Court of Chancery of the State of Delaware
4:38pm
8-K
uy349
14 Feb 23
Other Events
5:13pm
8-K
t8cc67ad y7mxc4ow8
10 Jan 23
Entry into a Material Definitive Agreement
4:05pm
8-K
7yl4e9ehnwgng wuo
9 Jan 23
SomaLogic Announces Preliminary Full Year 2022 Revenue and Provides Organizational and Strategic Updates
9:00am
8-K
ilg0iliais8v2m
14 Nov 22
SomaLogic Reports Third Quarter 2022 Financial Results
8:16am
8-K
32pu0 wgy
17 Oct 22
SomaLogic Announces the Appointment of Biotech Veteran Troy Cox as Executive Chairman of the Board of Directors
5:33pm
8-K
34043ed0as n3
30 Aug 22
Termination of a Material Definitive Agreement
5:24pm
8-K
uw63yj1vkyboac2axm
22 Aug 22
Departure of Directors or Certain Officers
4:30pm
8-K
8cndtpru50y9brg869s
15 Aug 22
SomaLogic Reports Second Quarter 2022 Financial Results
4:31pm
8-K
0c4dh
27 Jul 22
SomaLogic acquires DNA nanotechnology leader Palamedrix to develop the next-generation SomaScan® Assay
6:08am
8-K
tr17j
18 Jul 22
Departure of Directors or Certain Officers
11:06am
8-K
6bemrj r7bdayjx28
10 Jun 22
Submission of Matters to a Vote of Security Holders
8:05am
8-K
tqchfqr626dqnx 1vmj
12 May 22
SomaLogic Reports First Quarter 2022 Financial Results
4:14pm
8-K
pe0g72s6359hox29
29 Mar 22
SomaLogic Reports Fourth Quarter and Full Year 2021 Financial Results
4:15pm
8-K
kzt8nz8s5q4uda
29 Mar 22
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
4:13pm
8-K
uqbzs1qa
16 Feb 22
Entry into a Material Definitive Agreement
4:30pm
8-K
8ludksh3a7 95av
4 Feb 22
SomaLogic Provides 2022 Revenue Guidance in Conjunction with Analyst and Investor Meeting
8:06am